Ube Corporation · TSE:4208
Ube — FY2012 Earnings Presentation
28 slides from Ube's earnings presentation, May 10, 2013
Slide 1: FY2012 Consolidated Results, FY2013 Consolidated Forecasts
1 FY2012 Consolidated Results FY2013 Consolidated Forecasts May 10, 2013
Slide 2: Contents
2 Contents ・ FY12 Consolidated Results ・ FY13 Consolidated Forecasts ・ Appendix
Slide 3: FY12 Consolidated Results
FY12 Consolidated Results UBE
Slide 4: Scope of Consolidation
4 Scope of Consolidation － FY12 Consolidated Results － End of FY11 End of FY12 Change Item Notes (A) (B) （B) - （A) Number of Newly Included: 1 consolidated 67 67 0 Newly Excluded: 1 subsidiaries Number of Newly Included: None equity method 25 25 0 Newly Excluded: Nnone affiliates Total 92 92 0
Slide 5: Material Price Environmental Factors
5 Environmental Factors － FY12 Consolidated Results － （Billion Yen） FY11 FY12 Change Impacts on Item Consolidated (A) (B) (B) - (A) OP Income Exchange Rate Yen/$ 79.1 83.1 4.0 0.4 (CIF) $/ｔ 965 965 0 0.0 Naphtha (Domestic) Yen/KL 55,000 57,500 2,500 (-0.8) Material Price Benzene (Average of US and E
Slide 6: Major P/L & B/S Items
6 Major P/L & B/S Items － FY12 Consolidated Results － （Billion Yen） FY11 FY12 Change Item (A) (B) (B) - (A) Sales 638.6 626.0 -12.6 Operating income 46.0 29.9 -16.0 Ordinary income 40.8 28.0 -12.7 Net income 22.9 8.2 -14.7 End of FY11 End of FY12 Change Item (A) (B) (B) - (A) Total assets 664.9 685.
Slide 7: Non Operating Items
7 Non Operating Items － FY12 Consolidated Results － （Billion Yen） FY11 FY12 Change Item (A) (B) (B) - (A) Operating income 46.0 29.9 -16.0 Net interest income / expense -3.1 -2.6 0.5 Non operating income / loss Equity in earnings of unconsolidated subsidiaries 0.8 1.2 0.3 and affiliated companies Ne
Slide 8: Extraordinary Items
8 Extraordinary Items － FY12 Consolidated Results － （Billion Yen） FY11 FY12 Change Item (A) (B) (B) - (A) Ordinary income 40.8 28.0 -12.7 Loss on disposal of PP&E -2.5 -8.4 -5.8 Loss on impairment -2.0 -3.1 -1.0 Extraordinary income / loss Loss on related business -0.2 -2.7 -2.4 Others 1.6 2.0 0.4 T
Slide 9: Operating Income – Net Income
9 Operating Income – Net Income － FY12 Consolidated Results － （Billion Yen） FY11 FY12 Change Item (A) (B) (B) - (A) Operating income 46.0 29.9 -16.0 Non operating item -5.1 -1.9 3.2 Ordinary income 40.8 28.0 -12.7 Extraordinary item -3.2 -12.2 -8.9 Income before income tax and minority interest 37.5
Slide 10: Sales by Segment
10 Sales by Segment － FY12 Consolidated Results － （Billion Yen） FY11 FY12 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain -5.6 Chemicals & Plastics 231.0 219.3 -11.6 Synthetic rubber -6.0 Specialty Chemicals & Specialty products -3.9 Products 64.3 61.1 -3.2 Fine chemicals 0.6 Pharma
Slide 11: Operating Income by Segment
11 Operating Income by Segment － FY12 Consolidated Results － （Billion Yen） FY11 FY12 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain -14.1 Chemicals & Plastics 22.9 5.0 -17.9 Synthetic rubber -3.8 Specialty Chemicals & Specialty products -3.9 Products 5.4 1.2 -4.2 Fine chemicals -0.
Slide 12: Analysis of Operating Income
12 Analysis of Operating Income － FY12 Consolidated Results － （Billion Yen） Operating Income Segment FY11 FY12 Change Sales Fixed Price Others Volume Cost (A) (B) (B) - (A) *1 *2 Chemicals & Plastics 22.9 5.0 -17.9 -20.4 2.6 -0.2 0.1 Specialty Chemicals & Products 5.4 1.2 -4.2 -2.7 0.3 -0.6 -1.2 Pha
Slide 13: Consolidated Balance Sheet
13 Consolidated Balance Sheet － FY12 Consolidated Results － （Billion Yen） End of FY11 End of FY12 Change Item (A) (B) (B) - (A) Current assets 284.4 287.3 2.9 Assets Fixed assets 380.4 398.3 17.8 Total 664.9 685.8 20.9 Interest-bearing debts 253.9 246.6 -7.3 Liabilities Other liabilities 186.5 188.4
Slide 14: Consolidated Statements of Cash Flows
14 Consolidated Statements of Cash Flows － FY12 Consolidated Results － （Billion Yen） Item FY11 FY12 Income before income tax and minority interests 15.8 A.Cash flows from operating activities 40.6 46.1 Depreciation andamortization 31.3 Working capital 2.1, Tax payment -11.5, etc. Acquisition of PP&E
Slide 15: FY13 Consolidated Forecasts
15 FY13 Consolidated Forecasts
Slide 16: Scope of Consolidation
16 Scope of Consolidation － FY13 Consolidated Forecasts － End of FY12 End of FY13 Change Item Notes (A) (B) （B) - （A) Number of Newly Included: 1 consolidated 67 66 -1 Newly Excluded: 2 subsidiaries Number of Newly Included: None equity method 25 25 0 Newly Excluded: None affiliates Total 92 91 -1
Slide 17: Material Price Environmental Factors
17 Environmental Factors － FY13 Consolidated Forecasts － （Billion Yen） FY12 FY13 Change Impacts on Item Consolidated (A) (B) (B) - (A) OP Income Exchange Rate Yen/$ 83.1 95.0 11.9 1.0 (CIF) $/ｔ 965 950 -15 0.3 Naphtha (Domestic) Yen/KL 57,500 64,700 7,200 (-2.3) Material Price Benzene (Average of US
Slide 18: Major P/L & B/S Items
18 Major P/L & B/S Items － FY13 Consolidated Forecasts － （Billion Yen） FY12 FY13 Change Item (A) (B) (B) - (A) Sales 626.0 675.0 49.0 Operating income 29.9 34.0 4.1 Ordinary income 28.0 28.5 0.5 Net income 8.2 14.5 6.3 End of FY12 End of FY13 Change Item (A) (B) (B) - (A) Total assets 685.8 710.0 24
Slide 19: Operating Income – Net Income
19 Operating Income – Net Income － FY13 Consolidated Forecasts － （Billion Yen） FY12 FY13 Change Item (A) (B) (B) - (A) Operating income 29.9 34.0 4.1 Non operating item -1.9 -5.5 -3.6 Ordinary income 28.0 28.5 0.5 Extraordinary item -12.2 -3.5 8.7 Income before income tax and minority interest 15.8
Slide 20: Sales by Segment
20 Sales by Segment － FY13 Consolidated Forecasts － （Billion Yen） FY12 FY13 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain 23.9 Chemicals & Plastics 219.3 251.0 31.7 Synthetic rubber 7.7 Specialty Chemicals & Specialty products 9.9 Products 61.1 74.0 12.9 Fine chemicals 3.0 Pharmac
Slide 21: Operating Income by Segment
21 Operating Income by Segment － FY13 Consolidated Forecasts － （Billion Yen） FY12 FY13 Change Segment Major Factors (A) (B) (B) - (A) Caprolactam chain 0.2 Chemicals & Plastics 5.0 7.0 2.0 Synthetic rubber 1.7 Specialty Chemicals & Specialty products 2.5 Products 1.2 4.5 3.3 Fine chemicals 0.8 Pharm
Slide 22: Analysis of Operating Income
22 Analysis of Operating Income － FY13 Consolidated Forecasts － （Billion Yen） *1: Including both selling and purchase change *2: Including inventory valuation changes -2.8 *3: Including marginal profit on machinery products -0.5
Slide 23: Appendix
23 Appendix
Slide 24: Major Subsidiaries
24 Major Subsidiaries － FY12 Consolidated Results － （Billion Yen） Operating Sales income Subsidiaries and Affiliates Business change from FY12 FY11 UBE CHEMICALS (ASIA) PUBLIC CO., LTD. Manufacture and sales of caprolactam and polyamide resin 41.8 ↓ UBE CHEMICAL EUROPE, S.A. Manufacture and sales of
Slide 25: Management Indices
25 Management Indices FY11 FY12 FY13 Item Computation Unit (A) (B) (B) Net debt Net D/E Ratio /Equity capital Times 1.11 0.98 0.95 Equity capital Equity Ratio /Total assets % 30.0 31.4 32.0 Operating Income Operating margin /Sales % 7.2 4.8 5.0 Business income Return on Assets (ROA) /Total assets %
Slide 26: R&D Expenses, Capital Expenditure and Depreciation
26 R&D Expenses, Capital Expenditure and Depreciation （Billion Yen） Item FY11 FY12 FY13 R&D expenses 13.7 14.0 14.5 Capital expenditure 44.4 40.9 40.0 Depreciation (& Amortization) 32.9 31.3 33.0
Slide 27: Major Items for Capital Expenditure
27 Major Items for Capital Expenditure Segment Item Site Completion Chemicals&Plastics Production facilities for Butadiene rubbers (expansion) Chiba/Japan Feb./'14 Production facilities for Butadiene rubbers as a joint venture Malaysia FY14 Production facilities for nylon6 (expansion) Spain Sep./'14
Slide 28: Forward-looking statements notice
28 This presentation material contains forward-looking statements concerning UBE’s future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently availab